Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Webber

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Sports (Basel, Switzerland)|April 24, 2019
'Perhaps a Bit Different to What We Did Twenty Years Ago': Senior Teachers' Perceptions of Outdoor Adventure within Primary Education in EnglandChris Webber, Ashley Hardwell
Human Vaccines & Immunotherapeutics|June 16, 2015
Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adultsRaul Isturiz, Chris Webber
Vaccine|May 12, 2020
Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studiesChris Webber, Paula Peyrani, Paul Balmer, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 8, 2013
Candidate odours for a short form odorant identification testRanjit K Mal, Chris Webber, Desmond A Nunez
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 22, 2018
Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in AdolescentsLidia C Serra, Laura J York, Paul Balmer, et al.
Vaccine|October 25, 2022
Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccineLidia Serra, Chris Webber, Cindy Burman, et al.
Infectious Diseases and Therapy|March 19, 2018
A Review of Meningococcal Disease and Vaccination Recommendations for TravelersLidia C Serra, Laura J York, Amgad Gamil, et al.
European Journal of Internal Medicine|October 21, 2016
Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccinationFrancesco Blasi, Murat Akova, Paolo Bonanni, et al.
Vaccine|January 9, 2023
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old childrenClare L Cutland, Paula Peyrani, Chris Webber, et al.
Vaccine|February 9, 2017
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Chris Webber, Michael Patton, Scott Patterson, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Sports (Basel, Switzerland)|April 24, 2019
'Perhaps a Bit Different to What We Did Twenty Years Ago': Senior Teachers' Perceptions of Outdoor Adventure within Primary Education in EnglandChris Webber, Ashley Hardwell
Human Vaccines & Immunotherapeutics|June 16, 2015
Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adultsRaul Isturiz, Chris Webber
Vaccine|May 12, 2020
Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studiesChris Webber, Paula Peyrani, Paul Balmer, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 8, 2013
Candidate odours for a short form odorant identification testRanjit K Mal, Chris Webber, Desmond A Nunez
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 22, 2018
Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in AdolescentsLidia C Serra, Laura J York, Paul Balmer, et al.
Vaccine|October 25, 2022
Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccineLidia Serra, Chris Webber, Cindy Burman, et al.
Infectious Diseases and Therapy|March 19, 2018
A Review of Meningococcal Disease and Vaccination Recommendations for TravelersLidia C Serra, Laura J York, Amgad Gamil, et al.
European Journal of Internal Medicine|October 21, 2016
Community-acquired pneumonia in adults: Highlighting missed opportunities for vaccinationFrancesco Blasi, Murat Akova, Paolo Bonanni, et al.
Vaccine|January 9, 2023
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old childrenClare L Cutland, Paula Peyrani, Chris Webber, et al.
Vaccine|February 9, 2017
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Chris Webber, Michael Patton, Scott Patterson, et al.
Pageof 4